首页 > 最新文献

Journal of the ASEAN Federation of Endocrine Societies最新文献

英文 中文
Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents. 不同葡萄糖和脂肪含量的商业肠内营养液管理后血糖和甘油三酯的变化。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-01 DOI: 10.15605/jafes.040.02.06
Hiroaki Kato, Sho Miyatake, Ippei Yamaoka

Objective: To clarify whether reducing the energy ratio of carbohydrates and increasing the ratio of fats contribute to suppressing blood glucose elevation not only under normal conditions, but also under the effects of glucocorticoids.

Methodology: Three test enteral nutrition solutions, differing in energy ratios and used in actual clinical settings, were given to rats: HINEX E-Gel (ST) with 20% fat and 64% carbohydrate content; HINEX E-Gel LC (LC) with 34% fat and 50% carbohydrate content; and HINEX Renute (RN) with 50% fat and 26% carbohydrate content. The time course data of plasma glucose, triglyceride, and insulin levels after a single oral administration of the test EN solution were obtained in normal rats (Experiment 1) and hyperglycemia model rats treated with dexamethasone (Experiment 2).

Result: In both normal and dexamethasone-induced hyperglycemic rats, plasma glucose levels were lower in the groups given RN than in the groups given ST. The differences in EN solutions did not significantly affect plasma triglyceride and insulin levels in both rat models.

Conclusion: This study suggested that the EN solution that is high in fat and low in carbohydrate suppressed the post-administration increase of blood glucose levels even in a state of steroid-induced hyperglycemia with insulin resistance.

目的:阐明降低碳水化合物的能量比和增加脂肪的能量比是否不仅在正常情况下,而且在糖皮质激素的作用下,都有助于抑制血糖升高。方法:给大鼠注射三种不同能量比的肠内营养液:脂肪含量20%,碳水化合物含量64%的HINEX E-Gel (ST);HINEX E-Gel LC (LC),脂肪含量34%,碳水化合物含量50%;脂肪含量为50%,碳水化合物含量为26%的HINEX Renute (RN)。取正常大鼠(实验1)和地塞米松治疗的高血糖模型大鼠(实验2)单次口服试验EN溶液后血浆葡萄糖、甘油三酯和胰岛素水平的时间过程数据。结果:在正常和地塞米松诱导的高血糖大鼠中,RN组的血浆葡萄糖水平均低于st组,EN溶液的差异对两种模型大鼠血浆甘油三酯和胰岛素水平均无显著影响。结论:本研究提示,高脂低碳水化合物的EN溶液即使在激素性高血糖伴胰岛素抵抗的情况下,也能抑制给药后血糖水平的升高。
{"title":"Blood Glucose and Triglyceride Changes Following the Administration of Commercial Enteral Nutrition Solutions with Differing Glucose and Fat Contents.","authors":"Hiroaki Kato, Sho Miyatake, Ippei Yamaoka","doi":"10.15605/jafes.040.02.06","DOIUrl":"10.15605/jafes.040.02.06","url":null,"abstract":"<p><strong>Objective: </strong>To clarify whether reducing the energy ratio of carbohydrates and increasing the ratio of fats contribute to suppressing blood glucose elevation not only under normal conditions, but also under the effects of glucocorticoids.</p><p><strong>Methodology: </strong>Three test enteral nutrition solutions, differing in energy ratios and used in actual clinical settings, were given to rats: HINEX E-Gel (ST) with 20% fat and 64% carbohydrate content; HINEX E-Gel LC (LC) with 34% fat and 50% carbohydrate content; and HINEX Renute (RN) with 50% fat and 26% carbohydrate content. The time course data of plasma glucose, triglyceride, and insulin levels after a single oral administration of the test EN solution were obtained in normal rats (Experiment 1) and hyperglycemia model rats treated with dexamethasone (Experiment 2).</p><p><strong>Result: </strong>In both normal and dexamethasone-induced hyperglycemic rats, plasma glucose levels were lower in the groups given RN than in the groups given ST. The differences in EN solutions did not significantly affect plasma triglyceride and insulin levels in both rat models.</p><p><strong>Conclusion: </strong>This study suggested that the EN solution that is high in fat and low in carbohydrate suppressed the post-administration increase of blood glucose levels even in a state of steroid-induced hyperglycemia with insulin resistance.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"78-84"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680874/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Resistance Patterns of Urinary Tract Pathogens Isolated from Patients with Type 2 Diabetes Mellitus on Sodium Glucose Co-transporter 2 Inhibitors Admitted in a Tertiary Hospital in the Philippines: A Single-Center Retrospective Cohort Study. 菲律宾一家三级医院收治的2型糖尿病患者尿路病原菌对葡萄糖共转运蛋白2抑制剂的耐药模式:一项单中心回顾性队列研究
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-11-06 DOI: 10.15605/jafes.040.02.17
Catheryn Rose Rudinas, Ceryl Cindy Tan

Background: Congruent with the increasing prevalence of diabetes, a growing armamentarium of anti-diabetes medications has been introduced. Among these are sodium glucose co-transporter-2 inhibitors (SGLT2i).

Objectives: SGLT2i use has been linked to an increased incidence of urogenital infections. The study aims to compare resistance patterns of urinary tract isolates among patients with diabetes who are on SGLT2i and not on SGLT2i.

Methodology: Single-center retrospective cohort study. A total of 464 patients (75 on SGLT2i, 389 not on SGLT2i) with DM type 2 and urinary tract infection were included. Urine culture results were compared.

Results: A similar pattern of urinary tract isolates was found between groups except for C. albicans being more common in the SGLT2i group. There was no significant association between the presence of resistant urinary tract pathogens and the use of SGLT2i. There was no statistically significant difference in resistance rates between groups, except for imipenem (p = 0.015).

Conclusion: SGLT2i use per se does not play a pivotal role in mediating bacterial resistance in urinary tract pathogens among patients with DM type 2. We do not recommend for or against the use of specific antimicrobials based on SGLT2 inhibitor alone. Patient's clinical profile along with urine culture test results remain key factors in patient management.

背景:随着糖尿病患病率的增加,越来越多的抗糖尿病药物被引入。其中包括葡萄糖共转运蛋白-2抑制剂钠(SGLT2i)。目的:SGLT2i的使用与泌尿生殖系统感染的发生率增加有关。该研究旨在比较SGLT2i和非SGLT2i糖尿病患者尿路分离株的耐药模式。方法:单中心回顾性队列研究。共纳入464例2型糖尿病合并尿路感染患者(75例SGLT2i, 389例非SGLT2i)。比较尿培养结果。结果:除了白色念珠菌在SGLT2i组更常见外,两组间尿路分离株的模式相似。尿路耐药病原体的存在与SGLT2i的使用之间没有显著的关联。除亚胺培南耐药率外,各组耐药率差异无统计学意义(p = 0.015)。结论:使用SGLT2i本身在2型糖尿病患者尿路病原菌耐药中并不起关键作用。我们不建议支持或反对单独使用基于SGLT2抑制剂的特定抗菌剂。患者的临床资料和尿培养试验结果仍然是患者管理的关键因素。
{"title":"Resistance Patterns of Urinary Tract Pathogens Isolated from Patients with Type 2 Diabetes Mellitus on Sodium Glucose Co-transporter 2 Inhibitors Admitted in a Tertiary Hospital in the Philippines: A Single-Center Retrospective Cohort Study.","authors":"Catheryn Rose Rudinas, Ceryl Cindy Tan","doi":"10.15605/jafes.040.02.17","DOIUrl":"10.15605/jafes.040.02.17","url":null,"abstract":"<p><strong>Background: </strong>Congruent with the increasing prevalence of diabetes, a growing armamentarium of anti-diabetes medications has been introduced. Among these are sodium glucose co-transporter-2 inhibitors (SGLT2i).</p><p><strong>Objectives: </strong>SGLT2i use has been linked to an increased incidence of urogenital infections. The study aims to compare resistance patterns of urinary tract isolates among patients with diabetes who are on SGLT2i and not on SGLT2i.</p><p><strong>Methodology: </strong>Single-center retrospective cohort study. A total of 464 patients (75 on SGLT2i, 389 not on SGLT2i) with DM type 2 and urinary tract infection were included. Urine culture results were compared.</p><p><strong>Results: </strong>A similar pattern of urinary tract isolates was found between groups except for <i>C. albicans</i> being more common in the SGLT2i group. There was no significant association between the presence of resistant urinary tract pathogens and the use of SGLT2i. There was no statistically significant difference in resistance rates between groups, except for imipenem (<i>p</i> = 0.015).</p><p><strong>Conclusion: </strong>SGLT2i use per se does not play a pivotal role in mediating bacterial resistance in urinary tract pathogens among patients with DM type 2. We do not recommend for or against the use of specific antimicrobials based on SGLT2 inhibitor alone. Patient's clinical profile along with urine culture test results remain key factors in patient management.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"138-146"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680856/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hirata Syndrome Clinical Presentation and Management: A Single-Centre Experience. 平田综合征的临床表现和管理:单中心经验。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-18 DOI: 10.15605/jafes.040.02.15
Gurusangappa Mudagall, Uma Kaimal Saikia, Ashok Krishna Bhuyan, Abhamoni Baro

Background: Hirata syndrome, or Insulin Autoimmune Syndrome (IAS), is a rare condition characterized by hyperinsulinemic hypoglycemia due to autoantibodies targeting endogenous insulin. Its rarity and unique presentation make diagnosis and management challenging.

Objective: To analyze the clinical presentation, diagnostic methods, and management of IAS based on a single-center experience.

Methodology: This was a case series, conducted at a tertiary care center in northeast India, involving six cases diagnosed between January 2022 and April 2024. Clinical histories, including drug use and comorbidities, were reviewed. Laboratory analyses during hypoglycemic episodes assessed insulin, C-peptide, β-hydroxybutyrate, and cortisol levels. Extended OGTT and 72-hour fasting tests were used when spontaneous hypoglycemia was absent. Insulin autoantibodies (IAA) confirmed the diagnosis.

Results: Six IAS cases were identified, with most linked to α-lipoic acid in multivitamins and one to methimazole. Patients experienced recurrent postprandial hypoglycemia. Elevated insulin, C-peptide, and IAA levels confirmed the diagnosis. Management included discontinuation of causative drugs, dietary changes with frequent complex carbohydrate meals, and pharmacotherapy (acarbose or prednisolone). Follow-up showed resolution of hypoglycemia and normalization of IAA levels in all patients.

Conclusion: IAS should be considered in patients with hypoglycemia and a history of sulfhydryl-containing medications. Early diagnosis using IAA measurement and appropriate management, including drug discontinuation, dietary adjustments, and pharmacotherapy, is essential. Further research is needed to refine treatment strategies and understand the pathogenesis of this rare syndrome.

背景:Hirata综合征或胰岛素自身免疫性综合征(IAS)是一种罕见的疾病,其特征是由针对内源性胰岛素的自身抗体引起的高胰岛素性低血糖。其罕见和独特的表现使诊断和治疗具有挑战性。目的:基于单中心经验分析IAS的临床表现、诊断方法及处理。方法:这是一个在印度东北部三级保健中心进行的病例系列,涉及2022年1月至2024年4月期间诊断的6例病例。回顾了临床病史,包括药物使用和合并症。低血糖发作期间的实验室分析评估了胰岛素、c肽、β-羟基丁酸盐和皮质醇水平。无自发性低血糖时采用延长OGTT和72小时空腹试验。胰岛素自身抗体(IAA)证实了诊断。结果:鉴定出6例IAS,多数与复合维生素中的α-硫辛酸有关,1例与甲巯咪唑有关。患者反复出现餐后低血糖。胰岛素、c肽和IAA水平升高证实了诊断。治疗包括停用致病性药物,改变饮食,频繁进食复合碳水化合物,以及药物治疗(阿卡波糖或强的松龙)。随访显示,所有患者低血糖得到缓解,IAA水平恢复正常。结论:有低血糖和含巯基药物史的患者应考虑IAS。使用IAA测量进行早期诊断和适当的管理,包括停药、调整饮食和药物治疗,是必不可少的。需要进一步的研究来完善治疗策略并了解这种罕见综合征的发病机制。
{"title":"Hirata Syndrome Clinical Presentation and Management: A Single-Centre Experience.","authors":"Gurusangappa Mudagall, Uma Kaimal Saikia, Ashok Krishna Bhuyan, Abhamoni Baro","doi":"10.15605/jafes.040.02.15","DOIUrl":"10.15605/jafes.040.02.15","url":null,"abstract":"<p><strong>Background: </strong>Hirata syndrome, or Insulin Autoimmune Syndrome (IAS), is a rare condition characterized by hyperinsulinemic hypoglycemia due to autoantibodies targeting endogenous insulin. Its rarity and unique presentation make diagnosis and management challenging.</p><p><strong>Objective: </strong>To analyze the clinical presentation, diagnostic methods, and management of IAS based on a single-center experience.</p><p><strong>Methodology: </strong>This was a case series, conducted at a tertiary care center in northeast India, involving six cases diagnosed between January 2022 and April 2024. Clinical histories, including drug use and comorbidities, were reviewed. Laboratory analyses during hypoglycemic episodes assessed insulin, C-peptide, β-hydroxybutyrate, and cortisol levels. Extended OGTT and 72-hour fasting tests were used when spontaneous hypoglycemia was absent. Insulin autoantibodies (IAA) confirmed the diagnosis.</p><p><strong>Results: </strong>Six IAS cases were identified, with most linked to α-lipoic acid in multivitamins and one to methimazole. Patients experienced recurrent postprandial hypoglycemia. Elevated insulin, C-peptide, and IAA levels confirmed the diagnosis. Management included discontinuation of causative drugs, dietary changes with frequent complex carbohydrate meals, and pharmacotherapy (acarbose or prednisolone). Follow-up showed resolution of hypoglycemia and normalization of IAA levels in all patients.</p><p><strong>Conclusion: </strong>IAS should be considered in patients with hypoglycemia and a history of sulfhydryl-containing medications. Early diagnosis using IAA measurement and appropriate management, including drug discontinuation, dietary adjustments, and pharmacotherapy, is essential. Further research is needed to refine treatment strategies and understand the pathogenesis of this rare syndrome.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"159-164"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680870/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145701694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reninoma: A Rare Cause of Surgically Curable Hypertension and Secondary Hyperaldosteronism. 肾鞘瘤:手术可治愈的高血压和继发性醛固酮增多症的罕见病因。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-11-07 DOI: 10.15605/jafes.040.02.20
Gaayathri Krishnan, Lim Jing Li, Tee Hwee Ching, Serena Khoo

Reninoma is a rare cause of renin-induced hypertension commonly seen in young adults and adolescents. Here, we describe a case of reninoma presenting with hypertension in the young. Further investigation revealed elevated renin and aldosterone levels. Computed tomography of the kidneys showed a right-sided renal mass. A diagnosis of reninoma was made, and the patient underwent nephron-sparing surgery, which rendered her normotensive post-operatively.

肾鞘瘤是一种罕见的肾素性高血压的病因,常见于年轻人和青少年。在此,我们报告一例以高血压为表现的年轻肾盂瘤。进一步的调查显示肾素和醛固酮水平升高。肾脏电脑断层显示右侧肾肿块。诊断为肾鞘瘤,病人接受了保留肾的手术,使她术后血压正常。
{"title":"Reninoma: A Rare Cause of Surgically Curable Hypertension and Secondary Hyperaldosteronism.","authors":"Gaayathri Krishnan, Lim Jing Li, Tee Hwee Ching, Serena Khoo","doi":"10.15605/jafes.040.02.20","DOIUrl":"10.15605/jafes.040.02.20","url":null,"abstract":"<p><p>Reninoma is a rare cause of renin-induced hypertension commonly seen in young adults and adolescents. Here, we describe a case of reninoma presenting with hypertension in the young. Further investigation revealed elevated renin and aldosterone levels. Computed tomography of the kidneys showed a right-sided renal mass. A diagnosis of reninoma was made, and the patient underwent nephron-sparing surgery, which rendered her normotensive post-operatively.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"165-168"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680841/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and Genotypic Insights into Turner Syndrome: Emphasis on Cardiovascular Abnormalities. 临床和基因型洞察特纳综合征:重点心血管异常。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-11-10 DOI: 10.15605/jafes.040.02.24
Mounam Chattopadhyay, Anindya Mukherjee, Pranab Kumar Sahana

Objective: Turner syndrome (TS) is a genetic disorder characterized by X chromosome abnormalities in females. It presents with various clinical features, including short stature and cardiovascular anomalies. Limited awareness and diagnostic facilities contribute to the underdiagnosis of TS in India. The current study aims to explore genotype-phenotype associations with clinical characteristics and cardiovascular abnormalities in TS patients in India.

Methodology: A cross-sectional study involving 40 TS patients underwent clinical assessments and karyotyping. Data on demographics, anthropometry, Turner stigmata, cardiovascular evaluation, neurocognitive assessment and biochemical parameters were collected. The statistical analysis was conducted utilizing Statistical Package for Social Sciences (SPSS) version 27.0.

Results: Monosomy 45, X (55%) was the most prevalent genotype, with notable differences in age at diagnosis and height standard deviation score among genotypes. Thirty-five percent (35%) of participants had cardiovascular abnormalities, with a higher prevalence in the monosomy group. Lower IQ scores and increased thyroid autoimmunity were associated with specific genotypes. Additionally, a greater occurrence of skeletal and cutaneous stigmata, including cubitus valgus and multiple nevi, was observed in the monosomy group.

Conclusion: The study underscores the significance of genotype-phenotype associations in TS, emphasizing personalized management strategies. Early detection using sophisticated technologies like MRI, comprehensive assessments and assisted personalized management strategies to individual genetic profiles may improve cardiovascular and overall health outcomes in Turner syndrome patients.

目的:特纳综合征(TS)是一种以女性X染色体异常为特征的遗传性疾病。它具有多种临床特征,包括身材矮小和心血管异常。有限的认识和诊断设施导致印度对TS的诊断不足。本研究旨在探讨基因型-表型与印度TS患者临床特征和心血管异常的关联。方法:一项涉及40例TS患者的横断面研究进行了临床评估和核型分析。收集了人口统计学、人体测量、特纳柱头、心血管评估、神经认知评估和生化参数的数据。统计分析采用社会科学统计软件包(SPSS) 27.0版。结果:45x(55%)是最常见的基因型,各基因型在诊断年龄和身高标准差评分上存在显著差异。35%(35%)的参与者有心血管异常,单染色体组的患病率更高。较低的智商和甲状腺自身免疫增加与特定基因型相关。此外,在单体组中观察到更多的骨骼和皮肤红斑,包括肘外翻和多发痣。结论:本研究强调了TS中基因型-表型关联的重要性,强调了个性化的管理策略。利用核磁共振成像等先进技术进行早期检测,对个体基因图谱进行综合评估和辅助个性化管理策略,可能会改善特纳综合征患者的心血管和整体健康状况。
{"title":"Clinical and Genotypic Insights into Turner Syndrome: Emphasis on Cardiovascular Abnormalities.","authors":"Mounam Chattopadhyay, Anindya Mukherjee, Pranab Kumar Sahana","doi":"10.15605/jafes.040.02.24","DOIUrl":"10.15605/jafes.040.02.24","url":null,"abstract":"<p><strong>Objective: </strong>Turner syndrome (TS) is a genetic disorder characterized by X chromosome abnormalities in females. It presents with various clinical features, including short stature and cardiovascular anomalies. Limited awareness and diagnostic facilities contribute to the underdiagnosis of TS in India. The current study aims to explore genotype-phenotype associations with clinical characteristics and cardiovascular abnormalities in TS patients in India.</p><p><strong>Methodology: </strong>A cross-sectional study involving 40 TS patients underwent clinical assessments and karyotyping. Data on demographics, anthropometry, Turner stigmata, cardiovascular evaluation, neurocognitive assessment and biochemical parameters were collected. The statistical analysis was conducted utilizing Statistical Package for Social Sciences (SPSS) version 27.0.</p><p><strong>Results: </strong>Monosomy 45, X (55%) was the most prevalent genotype, with notable differences in age at diagnosis and height standard deviation score among genotypes. Thirty-five percent (35%) of participants had cardiovascular abnormalities, with a higher prevalence in the monosomy group. Lower IQ scores and increased thyroid autoimmunity were associated with specific genotypes. Additionally, a greater occurrence of skeletal and cutaneous stigmata, including cubitus valgus and multiple nevi, was observed in the monosomy group.</p><p><strong>Conclusion: </strong>The study underscores the significance of genotype-phenotype associations in TS, emphasizing personalized management strategies. Early detection using sophisticated technologies like MRI, comprehensive assessments and assisted personalized management strategies to individual genetic profiles may improve cardiovascular and overall health outcomes in Turner syndrome patients.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"132-137"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680842/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Adrenal Venous Sampling in the Management of Primary Aldosteronism: Single-Centered Cross-Sectional Study at a Tertiary Care Hospital in Sri Lanka. 肾上腺静脉取样在原发性醛固酮增多症治疗中的有效性:斯里兰卡一家三级医院的单中心横断面研究。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-11-06 DOI: 10.15605/jafes.040.02.23
Chathurangani Balasooriya, Supun Manathunga, Sujeeva Nagaratnam, Siddiqa Ozaal, Janeesha Liyanagunawardana, Gaya Katulanda

Introduction: Adrenal venous sampling (AVS) is the gold standard procedure to discriminate unilateral primary aldosteronism (UPA) from bilateral disease (BPA). AVS is technically demanding and is only performed in a limited number of centers in Sri Lanka. This study aimed to evaluate the effectiveness of AVS in the management of primary aldosteronism.

Methodology: Thirty-two patients who underwent AVS at the National Hospital of Sri Lanka from April 2021 to April 2023 were enrolled. Continuous and categorical variables were summarized with mean ± SD and proportions, respectively. Mean and standard deviation of contralateral suppression index (CSI) were estimated with an intercept-only Bayesian inference model.

Results: The adrenal veins were successfully cannulated in 12 (37.5%). Lateralization was established in 11 (91.7%), and one was diagnosed as having bilateral disease. There were no total failures. Right AV cannulation was unsuccessful in 18 (56.25%), out of which lateralization was demonstrated in 9 (50%), while the rest were considered inconclusive. Left AV cannulation was unsuccessful only in 2 (6.25%); one was lateralized, while the other remained inconclusive. Among patients classified as having unilateral disease, the estimated mean of the CSI was 0.33 (89% credible interval: 0.11-0.86).

Conclusion: Despite failure due to procedural difficulties, AVS remained useful in the management of patients with PA. CSI remains a useful tool when cannulation is unsuccessful, especially on the right side.

简介:肾上腺静脉取样(AVS)是区分单侧原发性醛固酮增多症(UPA)和双侧疾病(BPA)的金标准程序。AVS在技术上要求很高,仅在斯里兰卡的有限几个中心进行。本研究旨在评价AVS治疗原发性醛固酮增多症的有效性。方法:纳入了2021年4月至2023年4月在斯里兰卡国立医院接受AVS的32例患者。连续变量和分类变量分别用均值±SD和比例进行汇总。用仅截距贝叶斯推理模型估计对侧抑制指数(CSI)的均值和标准差。结果:肾上腺静脉插管成功12例(37.5%)。11例(91.7%)出现偏侧,1例诊断为双侧病变。没有完全失败。18例(56.25%)右房室插管不成功,其中9例(50%)显示偏侧,其余未确定。左侧房室插管失败2例(6.25%);一个是侧化的,而另一个仍然没有定论。在被分类为单侧疾病的患者中,CSI的估计平均值为0.33(89%可信区间:0.11-0.86)。结论:尽管由于操作困难而失败,AVS在治疗PA患者中仍然有用。当插管不成功时,CSI仍然是一个有用的工具,特别是在右侧。
{"title":"Effectiveness of Adrenal Venous Sampling in the Management of Primary Aldosteronism: Single-Centered Cross-Sectional Study at a Tertiary Care Hospital in Sri Lanka.","authors":"Chathurangani Balasooriya, Supun Manathunga, Sujeeva Nagaratnam, Siddiqa Ozaal, Janeesha Liyanagunawardana, Gaya Katulanda","doi":"10.15605/jafes.040.02.23","DOIUrl":"10.15605/jafes.040.02.23","url":null,"abstract":"<p><strong>Introduction: </strong>Adrenal venous sampling (AVS) is the gold standard procedure to discriminate unilateral primary aldosteronism (UPA) from bilateral disease (BPA). AVS is technically demanding and is only performed in a limited number of centers in Sri Lanka. This study aimed to evaluate the effectiveness of AVS in the management of primary aldosteronism.</p><p><strong>Methodology: </strong>Thirty-two patients who underwent AVS at the National Hospital of Sri Lanka from April 2021 to April 2023 were enrolled. Continuous and categorical variables were summarized with mean ± SD and proportions, respectively. Mean and standard deviation of contralateral suppression index (CSI) were estimated with an intercept-only Bayesian inference model.</p><p><strong>Results: </strong>The adrenal veins were successfully cannulated in 12 (37.5%). Lateralization was established in 11 (91.7%), and one was diagnosed as having bilateral disease. There were no total failures. Right AV cannulation was unsuccessful in 18 (56.25%), out of which lateralization was demonstrated in 9 (50%), while the rest were considered inconclusive. Left AV cannulation was unsuccessful only in 2 (6.25%); one was lateralized, while the other remained inconclusive. Among patients classified as having unilateral disease, the estimated mean of the CSI was 0.33 (89% credible interval: 0.11-0.86).</p><p><strong>Conclusion: </strong>Despite failure due to procedural difficulties, AVS remained useful in the management of patients with PA. CSI remains a useful tool when cannulation is unsuccessful, especially on the right side.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"126-131"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680867/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overweight and Obesity and Multimorbidity in Community-Living Older Persons in the Philippines. 菲律宾社区生活老年人的超重、肥胖和多病。
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-10-01 DOI: 10.15605/jafes.040.02.05
Maria Stella Giron, Shelley Ann de la Vega

Background: Overweight and obesity, as well as the coexistence of multimorbidity, have been recognized as global health challenges. However, less is known about the prevalence of obesity and multimorbidity among older people in the Philippines. This study sought to determine the prevalence of obesity and multimorbidity among community-living older people.

Methodology: A cross-sectional analysis of older persons ≥60 years from the Focused Intervention for Frail Older Adults Research and Development Program (FITforFrail). Height and weight were measured by body mass index as underweight, <18.5 kg/m2; normal, 18.5-22.9 kg/m2; overweight, 23-27.5 kg/m2; and obese, ≥27.5 kg/m2. Multimorbidity was defined as the presence of two or more chronic diseases, assessed as a self-reported physician's diagnosis.

Results: The prevalence of obesity was 15.4%, which was significantly more common among women (p <0.013) and nonsmokers (p <0.006). Multimorbidity, including overweight/obesity, was reported by 77.9% of older persons, and among older persons with overweight and obesity, multimorbidity was present in 76.5%. A higher number of chronic diseases were reported by older persons who were overweight and obese (p <0.006). Significantly more overweight and obese older women reported having multimorbidity (p <0.049) compared to older men. Hypertension, hyperlipidemia, musculoskeletal disorders and hyperuricemia were the most commonly reported chronic diseases among older persons with overweight and obesity.

Conclusion: The results of this study highlight the importance of overweight/obesity as a determinant of multimorbidity. Future research should look into gender differences in risk factors and multimorbidity patterns.

背景:超重和肥胖,以及多种疾病共存,已被公认为全球健康挑战。然而,人们对菲律宾老年人肥胖和多病的患病率知之甚少。本研究旨在确定社区生活老年人中肥胖和多病的患病率。方法:对体弱多病老年人重点干预研究与发展项目(fitfor虚弱)中年龄≥60岁的老年人进行横断面分析。用体重指数测量身高和体重为体重不足,2;正常,18.5-22.9 kg/m2;超重23-27.5 kg/m2;肥胖≥27.5 kg/m2。多病被定义为存在两种或两种以上的慢性疾病,由自我报告的医生诊断评估。结果:肥胖患病率为15.4%,其中女性更为常见(p p p p)结论:本研究结果强调了超重/肥胖作为多重发病的决定因素的重要性。未来的研究应着眼于风险因素和多病模式的性别差异。
{"title":"Overweight and Obesity and Multimorbidity in Community-Living Older Persons in the Philippines.","authors":"Maria Stella Giron, Shelley Ann de la Vega","doi":"10.15605/jafes.040.02.05","DOIUrl":"10.15605/jafes.040.02.05","url":null,"abstract":"<p><strong>Background: </strong>Overweight and obesity, as well as the coexistence of multimorbidity, have been recognized as global health challenges. However, less is known about the prevalence of obesity and multimorbidity among older people in the Philippines. This study sought to determine the prevalence of obesity and multimorbidity among community-living older people.</p><p><strong>Methodology: </strong>A cross-sectional analysis of older persons ≥60 years from the Focused Intervention for Frail Older Adults Research and Development Program (FITforFrail). Height and weight were measured by body mass index as underweight, <18.5 kg/m<sup>2</sup>; normal, 18.5-22.9 kg/m<sup>2</sup>; overweight, 23-27.5 kg/m<sup>2</sup>; and obese, ≥27.5 kg/m<sup>2</sup>. Multimorbidity was defined as the presence of two or more chronic diseases, assessed as a self-reported physician's diagnosis.</p><p><strong>Results: </strong>The prevalence of obesity was 15.4%, which was significantly more common among women (<i>p</i> <0.013) and nonsmokers (<i>p</i> <0.006). Multimorbidity, including overweight/obesity, was reported by 77.9% of older persons, and among older persons with overweight and obesity, multimorbidity was present in 76.5%. A higher number of chronic diseases were reported by older persons who were overweight and obese (<i>p</i> <0.006). Significantly more overweight and obese older women reported having multimorbidity (<i>p</i> <0.049) compared to older men. Hypertension, hyperlipidemia, musculoskeletal disorders and hyperuricemia were the most commonly reported chronic diseases among older persons with overweight and obesity.</p><p><strong>Conclusion: </strong>The results of this study highlight the importance of overweight/obesity as a determinant of multimorbidity. Future research should look into gender differences in risk factors and multimorbidity patterns.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"85-92"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680851/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adrenergic Storm with Obstructive Hydrocephalus: Atypical Neurological Presentation of Von Hippel-Lindau Disease with Bilateral Pheochromocytoma in an Adolescent. 肾上腺素能性风暴伴梗阻性脑积水:青少年Von Hippel-Lindau病伴双侧嗜铬细胞瘤的非典型神经学表现
IF 1.2 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-11-01 Epub Date: 2025-11-03 DOI: 10.15605/jafes.040.02.18
Jean Mun Cheah, Thai Lun Tan, Yue Hui Lau, Stefanie Kar Yan Hung, Fei Bing Yong, Sue Wen Lim, Xin-Yi Ooi, Hui Chin Wong, Sy Liang Yong

Pheochromocytoma is often not the first diagnosis considered for many neurological complaints, especially obstructive hydrocephalus. We report a case of Von Hippel-Lindau disease in an adolescent presenting with obstructive hydrocephalus due to adrenergic storm requiring emergency ventriculoperitoneal shunt. This vignette emphasizes the importance of an integral approach, particularly accurate diagnosis that would lead to targeted pharmacological therapy focusing on alphaa-drenergic receptor blockade, which was followed by total curative excision of pheochromocytoma in a timely fashion.

嗜铬细胞瘤通常不是许多神经系统疾病的第一诊断,尤其是阻塞性脑积水。我们报告一例希佩尔-林道病在一个青少年表现为梗阻性脑积水由于肾上腺素能风暴需要紧急脑室腹腔分流。这篇小短文强调了整体方法的重要性,特别是准确的诊断将导致靶向药物治疗,重点是α -胆碱能受体阻断,随后及时进行嗜铬细胞瘤的完全治愈性切除。
{"title":"Adrenergic Storm with Obstructive Hydrocephalus: Atypical Neurological Presentation of Von Hippel-Lindau Disease with Bilateral Pheochromocytoma in an Adolescent.","authors":"Jean Mun Cheah, Thai Lun Tan, Yue Hui Lau, Stefanie Kar Yan Hung, Fei Bing Yong, Sue Wen Lim, Xin-Yi Ooi, Hui Chin Wong, Sy Liang Yong","doi":"10.15605/jafes.040.02.18","DOIUrl":"10.15605/jafes.040.02.18","url":null,"abstract":"<p><p>Pheochromocytoma is often not the first diagnosis considered for many neurological complaints, especially obstructive hydrocephalus. We report a case of Von Hippel-Lindau disease in an adolescent presenting with obstructive hydrocephalus due to adrenergic storm requiring emergency ventriculoperitoneal shunt. This vignette emphasizes the importance of an integral approach, particularly accurate diagnosis that would lead to targeted pharmacological therapy focusing on alphaa-drenergic receptor blockade, which was followed by total curative excision of pheochromocytoma in a timely fashion.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 2","pages":"169-174"},"PeriodicalIF":1.2,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12680877/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145702218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Before Explaining Depression Solely Caused by Diabetes, All Other Causes Must Have Been Ruled Out. 在解释抑郁症完全由糖尿病引起之前,必须排除所有其他原因。
IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-01 Epub Date: 2025-04-19 DOI: 10.15605/jafes.040.01.12
Josef Finsterer
{"title":"Before Explaining Depression Solely Caused by Diabetes, All Other Causes Must Have Been Ruled Out.","authors":"Josef Finsterer","doi":"10.15605/jafes.040.01.12","DOIUrl":"10.15605/jafes.040.01.12","url":null,"abstract":"","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 1","pages":"134-135"},"PeriodicalIF":0.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097970/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Glycaemia: Socioeconomic Factors and Diabetes Distress are Associated with Health-Related Quality of Life in People with Type 2 Diabetes. 超越血糖:社会经济因素和糖尿病困扰与2型糖尿病患者健康相关的生活质量相关
IF 0.6 Q4 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-05-01 Epub Date: 2025-04-22 DOI: 10.15605/jafes.040.01.19
Suresh Rama Chandran, Gilbert Soh Keng Keat, Nur Nasyitah Binte Mohamed Salim, Xiaohui Xin, Gek Hsiang Lim, Daphne Gardner, Su-Yen Goh

Background: Diabetes is a complex multifactorial disease. Therapy focused only on managing glycaemia does not yield optimal health outcomes. Health-related Quality of Life (HRQOL) is a broad, subjective, and multidimensional concept gaining significance in diabetes care. The complex interplay of HRQOL and other factors must be addressed to achieve optimal health outcomes.

Objective: We aim to describe the factors associated with HRQOL in type 2 diabetes.

Methodology: A single-center cross-sectional short messaging service (SMS) survey invited adults with type 2 diabetes (T2D) with ≥1 clinic attendance in the past year. Participants completed the Problem Areas in Diabetes-5 (PAID-5), Diabetes Distress Scale-17 (DDS17), and European Quality of Life Score (EQ-5D-5L). Demographic and diabetes-related data were retrieved from electronic medical records. Multiple regression models were created with EQ-5D-5L Index score (HRQOL) as the dependent variable.

Result: A total of 1406 people with T2D participated, 46.4% women, mean (SD) age 61.1 (13.4) years, BMI 27.1 (5.4) kg/ m2, and HbA1c 8.0 (1.4)%. Of these, 60.9% had ≥1 microvascular and 23.8% had ≥1 macrovascular complication. Mean (SD) of EQ-5D-5L Index score was 0.81 (0.27), EQ5D Visual Analog Score (VAS) was 77.4 (23.8), total mean DDS17 score was 1.87 (0.93) and PAID-5 score was 5.04 (4.5). 26.9% and 11.3% had significant diabetes distress (DD) based on PAID-5 ≥8 and DDS17 ≥3. Multiple regression models revealed diabetes distress, a lower class of housing type, presence of macrovascular complication, higher BMI, older age, and female sex to be associated with a poorer EQ-5D-5L Index Score.

Conclusion: Multiple non-glycemic factors like sociodemographic, socioeconomic, diabetes distress, impact health-related QoL in people with type 2 diabetes.

背景:糖尿病是一种复杂的多因素疾病。仅关注血糖控制的治疗不能产生最佳的健康结果。健康相关生活质量(HRQOL)是一个广泛的、主观的、多维的概念,在糖尿病治疗中具有重要意义。必须解决HRQOL和其他因素之间复杂的相互作用,以实现最佳的健康结果。目的:探讨影响2型糖尿病患者HRQOL的相关因素。方法:一项单中心横断面短信服务(SMS)调查邀请了过去一年中就诊次数≥1次的2型糖尿病(T2D)成年人。参与者完成了糖尿病问题领域-5 (PAID-5)、糖尿病痛苦量表-17 (DDS17)和欧洲生活质量评分(EQ-5D-5L)。从电子病历中检索人口统计和糖尿病相关数据。以EQ-5D-5L指数评分(HRQOL)为因变量建立多元回归模型。结果:共有1406例T2D患者参与,其中46.4%为女性,平均(SD)年龄61.1(13.4)岁,BMI 27.1 (5.4) kg/ m2, HbA1c 8.0(1.4%)%。其中微血管并发症≥1例的占60.9%,大血管并发症≥1例的占23.8%。EQ-5D-5L指数评分的平均(SD)为0.81 (0.27),EQ5D视觉模拟评分(VAS)为77.4(23.8),总平均DDS17评分为1.87 (0.93),PAID-5评分为5.04(4.5)。根据PAID-5≥8和DDS17≥3,26.9%和11.3%的患者存在显著的糖尿病窘迫(DD)。多元回归模型显示,糖尿病困扰、低等级住房类型、存在大血管并发症、高BMI、年龄较大和女性与较低的EQ-5D-5L指数得分相关。结论:社会人口学、社会经济、糖尿病困扰等多种非血糖因素影响2型糖尿病患者健康相关生活质量。
{"title":"Beyond Glycaemia: Socioeconomic Factors and Diabetes Distress are Associated with Health-Related Quality of Life in People with Type 2 Diabetes.","authors":"Suresh Rama Chandran, Gilbert Soh Keng Keat, Nur Nasyitah Binte Mohamed Salim, Xiaohui Xin, Gek Hsiang Lim, Daphne Gardner, Su-Yen Goh","doi":"10.15605/jafes.040.01.19","DOIUrl":"10.15605/jafes.040.01.19","url":null,"abstract":"<p><strong>Background: </strong>Diabetes is a complex multifactorial disease. Therapy focused only on managing glycaemia does not yield optimal health outcomes. Health-related Quality of Life (HRQOL) is a broad, subjective, and multidimensional concept gaining significance in diabetes care. The complex interplay of HRQOL and other factors must be addressed to achieve optimal health outcomes.</p><p><strong>Objective: </strong>We aim to describe the factors associated with HRQOL in type 2 diabetes.</p><p><strong>Methodology: </strong>A single-center cross-sectional short messaging service (SMS) survey invited adults with type 2 diabetes (T2D) with ≥1 clinic attendance in the past year. Participants completed the Problem Areas in Diabetes-5 (PAID-5), Diabetes Distress Scale-17 (DDS17), and European Quality of Life Score (EQ-5D-5L). Demographic and diabetes-related data were retrieved from electronic medical records. Multiple regression models were created with EQ-5D-5L Index score (HRQOL) as the dependent variable.</p><p><strong>Result: </strong>A total of 1406 people with T2D participated, 46.4% women, mean (SD) age 61.1 (13.4) years, BMI 27.1 (5.4) kg/ m<sup>2</sup>, and HbA1c 8.0 (1.4)%. Of these, 60.9% had ≥1 microvascular and 23.8% had ≥1 macrovascular complication. Mean (SD) of EQ-5D-5L Index score was 0.81 (0.27), EQ5D Visual Analog Score (VAS) was 77.4 (23.8), total mean DDS17 score was 1.87 (0.93) and PAID-5 score was 5.04 (4.5). 26.9% and 11.3% had significant diabetes distress (DD) based on PAID-5 ≥8 and DDS17 ≥3. Multiple regression models revealed diabetes distress, a lower class of housing type, presence of macrovascular complication, higher BMI, older age, and female sex to be associated with a poorer EQ-5D-5L Index Score.</p><p><strong>Conclusion: </strong>Multiple non-glycemic factors like sociodemographic, socioeconomic, diabetes distress, impact health-related QoL in people with type 2 diabetes.</p>","PeriodicalId":41792,"journal":{"name":"Journal of the ASEAN Federation of Endocrine Societies","volume":"40 1","pages":"72-79"},"PeriodicalIF":0.6,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12097981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144143946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the ASEAN Federation of Endocrine Societies
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1